Zai Lab Limited
再鼎醫藥有限公司

28 SEP 2020

Zai Lab Limited, founded in 2014, is an innovative, research-based, commercial-stage biopharmaceutical company focused on bringing innovative therapies for cancer, infectious and autoimmune diseases to patients in China and around the world. The Company has assembled a broad and highly differentiated innovative portfolio of 16 potential best-in-class/first-in-class products and drug candidates. The Company’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.

再鼎醫藥有限公司*（「公司」）成立於2014年，是一間創新型、立足研發及處於商業階段的生物製藥公司，專注為中國及全球的患者提供腫瘤、抗感染及自體免疫性疾病的創新療法。公司建立了廣泛及高度差異化的創新產品組合，包括16種具有潛在全球同類最佳/同類首創潛力的產品及候選藥物。公司的願景是成為一家全面整合的生物製藥公司，發現、開發、生產及商業化其產品組合，為全球人類健康作出貢獻。

* For identification purpose only / 僅供識別